Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16)
- Status
- UNKNOWN
- Phase
- PHASE2
A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Molecular Evaluation in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
- Status
- COMPLETED
- Phase
- PHASE4
Olaparib In Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Study of SV-BR-1-GM With Retifanlimab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Patterns of Prescribing and Monitoring of Palbociclib
- Status
- COMPLETED
- Phase
- N/A
Palbociclib in Real World Practice
- Status
- COMPLETED
- Phase
- N/A